PEPTONIC medical AB (XSAT:PMED) 5-Year EBITDA Growth Rate : 17.90% (As of Mar. 2024)

View and export this data going back to 2014. Start your Free Trial

What is PEPTONIC medical AB 5-Year EBITDA Growth Rate?

PEPTONIC medical AB's EBITDA per Share for the three months ended in Mar. 2024 was kr-0.00.

During the past 3 years, the average EBITDA Per Share Growth Rate was 37.60% per year. During the past 5 years, the average EBITDA Per Share Growth Rate was 17.90% per year. During the past 10 years, the average EBITDA Per Share Growth Rate was 15.30% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average EBITDA per share growth rate.

During the past 11 years, the highest 3-Year average EBITDA Per Share Growth Rate of PEPTONIC medical AB was 39.30% per year. The lowest was -20.90% per year. And the median was 10.70% per year.

Competitive Comparison of PEPTONIC medical AB's 5-Year EBITDA Growth Rate

For the Drug Manufacturers - Specialty & Generic subindustry, PEPTONIC medical AB's 5-Year EBITDA Growth Rate, along with its competitors' market caps and 5-Year EBITDA Growth Rate data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

PEPTONIC medical AB's 5-Year EBITDA Growth Rate Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, PEPTONIC medical AB's 5-Year EBITDA Growth Rate distribution charts can be found below:

* The bar in red indicates where PEPTONIC medical AB's 5-Year EBITDA Growth Rate falls into.

PEPTONIC medical AB 5-Year EBITDA Growth Rate Calculation

This is the 5-year average growth rate of EBITDA per Share. The growth rate is calculated with least square regression.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average EBITDA per share growth rate.

PEPTONIC medical AB (XSAT:PMED) 5-Year EBITDA Growth Rate Explanation

EBITDA per Share is the amount of Earnings Before Interest, Taxes, Depreciation, and Amortization (EBITDA) per outstanding share of the company's stock.

Earnings Before Interest, Taxes, Depreciation, and Amortization (EBITDA) is what the company earns before it expenses interest, taxes, depreciation and amortization.

5-Year EBITDA Growth Rate gives an overview of the company's growth in operating profitability and is an important factor used in calculating Peter Lynch Fair Value.

PEPTONIC medical AB 5-Year EBITDA Growth Rate Related Terms

Thank you for viewing the detailed overview of PEPTONIC medical AB's 5-Year EBITDA Growth Rate provided by GuruFocus.com. Please click on the following links to see related term pages.

PEPTONIC medical AB (XSAT:PMED) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » PEPTONIC medical AB (XSAT:PMED) » Definitions » 5-Year EBITDA Growth Rate

Comparable Companies

Traded in Other Exchanges

28L:Germany

Address

Gustavslundsvägen 143, Bromma, SWE, SE-167 51

Website

https://www.peptonicmedical.se

PEPTONIC medical AB is a pharmaceutical company. It is engaged in developing oxytocin-based products for the treatment of menopausal symptoms, such as vaginal atrophy and vaginal dryness. Oxytocin is for medical use and offers an alternative to estrogen and estrogen-like acting compounds for menopausal and postmenopausal women. The company is based in Sweden.

PEPTONIC medical AB (XSAT:PMED) Headlines

No Headlines